Jeffrey R. Stewart, an officer of AbbVie Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 40,619 shares of AbbVie common stock acquired through a stock option exercise on the same date.
Key Highlights
- Proposed seller: Jeffrey R. Stewart, identified as an officer of AbbVie Inc.
- Shares proposed for sale: 40,619 shares of AbbVie common stock.
- Aggregate market value: $11,925,848.07, as stated in the filing.
- Source of shares: Stock option exercise from the issuer, acquired on November 9, 2026, with payment made in cash.
- Approximate date of sale: November 9, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services, New York.
- Prior three-month sales: The filing reports nothing to report for securities sold during the past three months.
- Shares outstanding: 1,767,616,306 shares of AbbVie common stock, according to the filing.
AbbVie Officer Files Rule 144 Notice for Option-Exercised Shares
According to the Form 144 filing submitted on November 9, 2026, Jeffrey R. Stewart, an officer of AbbVie Inc. (NYSE:ABBV), provided notice of a proposed sale of 40,619 shares of AbbVie common stock. The filing indicates the shares were acquired on November 9, 2026, via a stock option exercise from the issuer, with the purchase price paid in cash on the same date. The aggregate market value of the proposed sale is listed as $11,925,848.07.
The proposed sale is to be executed on the New York Stock Exchange, with Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, named as the broker. The filing reports that Stewart had no securities sales in the three months preceding the notice date that require disclosure under Rule 144.
The filing further states that the person for whose account the securities are to be sold represents, by signing the notice, that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." Total shares of AbbVie common stock outstanding are listed in the filing as 1,767,616,306.
What Was Disclosed
AbbVie officer Jeffrey R. Stewart filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 40,619 common shares acquired through a stock option exercise, with an aggregate market value of $11,925,848.07, to be sold on the NYSE.



Please wait processing your request...